About us

Since its establishment in 2010, the Helse Nord Tuberculosis Initiative (HNTI) has grown in scope and quality of research. The establishment and growth have been enabled by the core funding from the Helse Nord RHF. The growth of the HNTI and the expansion of our themes allows it to be a key player in the global effort to eliminate TB and other infectious diseases. As a center of excellence, the HNTI will become an active participant in the global scientific conversation on the effort to END TB and communicable diseases.

Our Themes

TB Diagnostics

Exploring improved algorithms and tests

for diagnosing TB

TB Drug Trials

Identifying better (short and effective) TB drug regimens.

Genomics

A new and upcoming theme within the group

Social Sciences

Breaching the lines between people and infectious diseases

Microbiology

Interventions to address the burden of infections in Malawi

Collaborations

Networking and communicating locally and internationally

Some of our Publications from 2021

Utility of Xpert MTB/RIF Ultra and digital chest radiography for the diagnosis and treatment of TB in people living with HIV: a randomised controlled trial (XACT-TB)

Mukoka M, Twabi HH, Msefula C, Semphere R, et al.

Transactions of the Royal Society of Tropical Medicine and Hygiene 2022; 0 : 1-10.

Pattern of abnormalities amongst chest X‐rays of adults undergoing computer‐assisted digital chest X‐ray screening for tuberculosis in Peri‐Urban Blantyre, Malawi: A cross‐sectional study
Twabi HH, Semphere R, Mukoka M, et al.

Tropical Medicine and International Health 2021; 26: 1427-1437.

Non-Tuberculous Mycobacterial Pulmonary Disease identified during community-based screening for Mycobacterium Tuberculosis: a case report

Twabi HH, Mukoka-Thindwa M, Shani D, et al.

Malawi Medical Journal 2021; 3.

Click here to view more